| Literature DB >> 31905719 |
Vangelis Smyrniotopoulos1, Anna Cláudia de Andrade Tomaz1,2, Maria de Fátima Vanderlei de Souza2, Emídio Vasconcelos Leitão da Cunha2, Robert Kiss3, Véronique Mathieu4,5, Efstathia Ioannou1, Vassilios Roussis1.
Abstract
Eight new (1-8) structurally diverse diterpenes featuring five different carbocycles were isolated from the organic extracts of the red alga Sphaerococcus coronopifolius collected from the coastline of the Ionian Sea in Greece. The structures of the new natural products, seven of which were halogenated, and the relative configuration of their stereocenters were determined on the basis of comprehensive spectroscopic analyses, including NMR and HRMS data. Compounds 5 and 8 were found to possess in vitro antitumor activity against one murine and five human cancer cell lines with mean IC50 values 15 and 16 μM, respectively.Entities:
Keywords: Sphaerococcus coronopifolius; antitumor activity; halogenated diterpenes; red algae; structure elucidation
Mesh:
Substances:
Year: 2019 PMID: 31905719 PMCID: PMC7024270 DOI: 10.3390/md18010029
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of compounds 1–8.
13C NMR data (δ in ppm, multiplicity) of compounds 1–8.
| No. | 1 a | 2 a | 3 b | 4 a | 5 a | 6 a | 7 a | 8 a |
|---|---|---|---|---|---|---|---|---|
| 1 | 49.4 (d) | 49.3 (d) | 34.7 (d) | 81.9 (d) | 28.1 (t) | 29.7 (t) | 127.0 (d) | 127.7 (d) |
| 2 | 35.6 (t) | 34.0 (t) | 41.0 (t) | 25.1 (t) | 32.2 (t) | 24.8 (t) | 23.3 (t) | 22.7 (t) |
| 3 | 48.8 (d) | 48.9 (d) | 139.0 (q) | 48.3 (d) | 55.8 (d) | 44.4 (d) | 52.0 (d) | 42.0 (d) |
| 4 | 51.9 (q) | 51.3 (q) | 52.8 (q) | 43.5 (q) | 153.3 (q) | 133.3 (q) | 38.2 (q) | 40.1 (q) |
| 5 | 22.8 (t) | 22.9 (t) | 24.4 (t) | 24.0 (t) | 25.0 (t) | 125.7 (d) | 31.6 (t) | 24.7 (t) |
| 6 | 37.8 (t) | 37.7 (t) | 38.7 (t) | 37.0 (t) | 39.3 (t) | 40.1 (t) | 34.8 (t) | 29.1 (t) |
| 7 | 41.5 (q) | 41.4 (q) | 41.0 (q) | 39.3 (q) | 41.4 (q) | 44.7 (q) | 39.5 (q) | 39.8 (q) |
| 8 | 68.5 (d) | 68.6 (d) | 68.5 (d) | 68.7 (d) | 164.8 (d) | 68.0 (d) | 60.6 (d) | 83.8 (d) |
| 9 | 31.0 (t) | 30.9 (t) | 30.9 (t) | 30.6 (t) | 124.6 (d) | 31.1 (t) | 30.9 (t) | 38.9 (t) |
| 10 | 43.6 (t) | 43.7 (t) | 43.3 (t) | 42.5 (t) | 200.6 (q) | 40.8 (t) | 38.5 (t) | 216.9 (q) |
| 11 | 73.6 (q) | 73.5 (q) | 72.9 (q) | 72.6 (q) | 73.5 (q) | 71.7 (q) | 75.7 (q) | 76.3 (q) |
| 12 | 47.6 (d) | 47.9 (d) | 56.4 (d) | 52.0 (d) | 58.5 (d) | 62.3 (d) | 53.6 (d) | 42.9 (d) |
| 13 | 44.8 (d) | 44.5 (d) | 39.0 (d) | 31.8 (d) | 124.2 (d) | 128.1 (d) | 45.4 (d) | 35.4 (d) |
| 14 | 25.9 (d) | 52.5 (d) | 43.1 (t) | 40.9 (d) | 136.1 (d) | 133.0 (d) | 131.9 (d) | 129.0 (d) |
| 15 | 32.9 (s) | 33.2 (s) | 32.7 (s) | 30.3 (s) | 25.2 (s) | 30.9 (s) | 35.4 (s) | 31.2 (s) |
| 16 | 16.6 (s) | 16.3 (s) | 16.9 (s) | 16.0 (s) | 20.4 (s) | 15.2 (s) | 28.1 (s) | 17.2 (s) |
| 17 | 50.2 (t) | 48.6 (t) | 43.9 (t) | 34.2 (t) | 112.3 (t) | 19.1 (s) | 17.7 (s) | 40.6 (t) |
| 18 | 28.3 (d) | 28.3 (d) | 119.9 (q) | 27.6 (d) | 29.9 (d) | 30.4 (d) | 26.5 (d) | 25.8 (d) |
| 19 | 23.4 (s) | 23.4 (s) | 20.3 (s) | 15.8 (s) | 20.7 (s) | 21.1 (s) | 23.4 (s) | 19.3 (s) |
| 20 | 18.7 (s) | 18.8 (s) | 23.9 (s) | 22.6 (s) | 21.5 (s) | 21.3 (s) | 16.6 (s) | 25.8 (s) |
| OMe | – | – | – | 55.9 (s) | – | – | – | 57.5 (s) |
a Recorded in CDCl3 at 50 MHz. b Recorded in CDCl3 at 75 MHz.
1H NMR data (δ in ppm, multiplicity, J in Hz) of compounds 1–4.
| No. | 1 a | 2 a | 3 b | 4 a | ||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2.88 | br s | 2.90 | br d 4.1 | 2.13 | br s | 3.58 | ddd 7.5, 7.5, 1.4 |
| 2 | 1.34 | m | α 1.48 | m | α 1.89 | br d 14.4 | α 1.60 | m |
| 3 | 1.17 | m | 1.14 | m | – | 1.61 | m | |
| 5 | α 1.73 | m | α 1.76 | m | α 2.60 | ddd 13.9, 13.8, 4.1 | α 1.62 | ddd 13.2, 13.2, 4.4 |
| 6 | α 1.86 | ddd 12.9, 4.0, 2.2 | α 1.88 | ddd 13.2, 4.7, 2.3 | α 1.92 | ddd 13.2, 4.2, 3.0 | α 1.90 | ddd 13.2, 4.4, 2.9 |
| 8 | 4.09 | dd 12.6, 4.0 | 4.07 | dd 12.6, 4.1 | 3.97 | dd 12.6, 4.2 | 4.04 | dd 12.8, 4.0 |
| 9 | α 2.48 | dddd 13.4, 13.4, 12.6, 4.6 | α 2.47 | dddd 13.4, 13.4, 12.6, 4.7 | α 2.48 | dddd 13.8, 13.8, 12.6, 4.8 | α 2.49 | dddd 13.4, 13.4, 12.8, 4.4 |
| 10 | α 1.59 | ddd 14.5, 4.6, 3.0 | α 1.58 | ddd 14.3, 4.7, 2.9 | α 1.58 | m | α 1.67 | ddd 13.4, 4.4, 2.9 |
| 12 | 1.97 | d 12.1 | 1.93 | d 12.0 | 1.07 | d 11.0 | 1.49 | d 9.9 |
| 13 | 1.81 | br d 12.1 | 1.74 | m | 1.77 | ddd 11.0, 8.4, 4.8 | 2.02 | m |
| 14 | 3.98 | dd 8.6, 5.6 | 4.03 | dd 8.5, 5.0 | α 1.66 | ddd 12.0, 8.4, 2.4 | 2.27 | dd 7.3, 1.4 |
| 15 | 1.56 | s | 1.49 | s | 1.14 | s | 1.10 | s |
| 16 | 1.16 | s | 1.16 | s | 1.18 | s | 1.05 | s |
| 17 | a 2.60 | dd 14.2, 5.6 | a 2.52 | dd 14.3, 5.0 | a 1.83 | br d 9.6 | a 2.44 | dd 9.5, 7.3 |
| 18 | 1.72 | m | 1.71 | m | – | 2.04 | m | |
| 19 | 0.85 | d 6.7 | 0.86 | d 6.4 | 1.84 | br s | 0.91 | d 6.9 |
| 20 | 0.84 | d 6.7 | 0.85 | d 6.4 | 1.57 | br s | 0.89 | d 6.9 |
| OMe | – | – | – | 3.30 | s |
a Recorded in CDCl3 at 400 MHz; b Recorded in CDCl3 at 600 MHz.
Figure 2(a) COSY and key HMBC correlations and (b) important NOE interactions for iodocoronol (1).
Figure 3(a) COSY and key HMBC correlations and (b) important NOE interactions for bromotetrasphaereniol (3).
Figure 4(a) COSY and key HMBC correlations and (b) important NOE interactions for 1-methoxy-ioniol I (4).
1H NMR data (δ in ppm, multiplicity, J in Hz) of compounds 5–8.
| No. | 5 a | 6 a | 7 a | 8 a | ||||
|---|---|---|---|---|---|---|---|---|
| 1 | α 2.28 | m | a 2.23 | m | 5.55 | dm 10.2 | 5.69 | dm 10.5 |
| 2 | a 1.85 | m | α 1.25 | m | α 1.93 | m | α 1.98 | m |
| 3 | 1.76 | m | 2.01 | ddd 12.0, 10.2, 4.3 | 1.57 | ddd 10.5, 7.3, 3.2 | 1.74 | m |
| 5 | a 2.09 | dt 16.6, 4.6 | 5.27 | dd 12.0, 6.2 | α 1.49 | m | α 1.73 | ddd 14.0, 14.0, 4.0 |
| 6 | 1.73 | m | α 2.23 | dd 14.0, 6.2 | α 1.49 | m | α 0.97 | ddd 14.0, 4.0, 2.9 |
| 8 | 6.81 | d 10.2 | 4.00 | dd 12.6, 4.1 | 4.55 | dd 12.9, 4.7 | 3.09 | br d 6.9 |
| 9 | 5.92 | d 10.2 | α 2.53 | dddd 13.8, 13.8, 12.6, 4.4 | α 2.53 | dddd 13.1, 13.1, 12.9, 4.4 | α 2.81 | dd 18.4, 6.9 |
| 10 | – | α 1.69 | ddd 14.3, 4.4, 2.6 | α 1.45 | ddd 14.0, 4.4, 3.8 | – | ||
| 12 | 2.13 | d 10.0 | 1.79 | d 9.6 | 1.74 | dd 12.3, 1.8 | 2.46 | d 12.9 |
| 13 | 5.60 | ddd 15.8, 10.0, 1.1 | 5.27 | dd 14.9, 9.6 | 1.93 | dm 12.3 | 2.71 | dm 12.9 |
| 14 | 5.72 | dt 15.8, 6.7 | 5.18 | ddd 14.9, 10.5, 2.2 | 5.80 | dm 10.2 | 5.95 | br d 10.5 |
| 15 | 1.20 | s | 1.06 | s | 1.33 | s | 1.29 | s |
| 16 | 1.27 | s | 1.28 | s | 1.34 | s | 0.76 | s |
| 17 | a 4.87 | br s | 1.52 | br s | 0.77 | s | a 3.93 | d 10.5 |
| 18 | 1.42 | br hept 6.6 | 1.43 | dhept 10.2, 6.7 | 2.13 | dhept 7.0, 3.2 | 1.94 | dhept 6.7, 2.0 |
| 19 | 0.85 | d 6.6 | 0.90 | d 6.7 | 0.86 | d 7.0 | 0.87 | d 6.7 |
| 20 | 0.76 | d 6.6 | 0.67 | d 6.7 | 0.78 | d 7.0 | 0.93 | d 6.7 |
| OMe | – | – | – | 3.36 | s | |||
| 11OH | – | – | – | 3.48 | s |
a Recorded in CDCl3 at 400 MHz.
Figure 5Important NOE interactions for (a) corotrienone (5) and (b) iso-bromocorodienol (6).
Figure 6Important NOE interactions for (a) debromosphaerol (7) and (b) 8-methoxy-dihydro-sphaerococcenol (8).
In vitro growth inhibitory activity (IC50 values in μM) of compounds 1–8 and doxorubicin used as positive control.
| Human Cancer | Murine Cancer | ||||||
|---|---|---|---|---|---|---|---|
| Compound | A549 | Hs683 | MCF7 | SKMEL28 | U373 | B16F10 | Mean ± SEM |
|
| 84 | 66 | 50 | >100 | 98 | 69 | >78 |
|
| 55 | 50 | 48 | 82 | 86 | 68 | 65 ± 7 |
|
| 48 | 40 | 43 | 62 | 81 | 56 | 55 ± 7 |
|
| 68 | 52 | 46 | >100 | >100 | 49 | >69 |
|
| 20 | 18 | 9 | 23 | 11 | 8 | 15 ± 3 |
|
| 42 | 40 | 41 | 35 | 32 | 58 | 41 ± 4 |
|
| 42 | 35 | 45 | 72 | 65 | 27 | 48 ± 8 |
|
| 17 | 15 | 10 | 25 | 13 | 16 | 16 ± 2 |
| Doxorubicin | 0.45 | 0.36 | 0.16 | 0.44 | 0.33 | n.d.a | 0.35 ± 0.03 |
a Not determined.